Talking HealthTech

Taking a lifesciences company global: what to expect from an investor perspective. Paul Anderson - Orthocell. Investor Meets Innovator Takes Over Talking HealthTech!

Dec 25, 2023
Paul Anderson, an expert in lifesciences global expansion, discusses the challenges and benefits of funding growth, communicating the value of lifesciences investments, retaining IP in Western Australia, and exciting developments of Orthocell.
Ask episode
Chapters
Transcript
Episode notes